Aristotelis Tsirigos

Senior study investigator, Perlmutter Cancer Center, NYU Langone Health

Appears in 1 story

Stories

Pancreatic cancer rewrites its DNA to evade treatment, study finds

Quoted on clinical trials of MYC and TIGIT inhibitors already underway

Pancreatic cancer kills about 85 percent of patients within five years of diagnosis. A new study tracing 443,451 individual cancer cells from 62 tumors shows part of the reason: the cancer continually reshapes its genetic makeup, spawning cell populations that resist treatment and spread.

Updated 2 hours ago